TG Therapeutics Option Alert: May 16 $21 Calls Sweep (4) near the Ask: 407 vs 6898 OI; Earnings 4/30 Before Open [est] 

TG Therapeutics Option Alert: May 16 $21 Calls Sweep (4) near the Ask: 407 @ $14.9 vs 6898 OI; Earnings 4/30 Before Open [est] Ref=$35.65

TG Therapeutics

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Bitcoin WULF MARA MSTR COIN HUT

Equities

Mid Cap

News

Movers

Trading Ideas

ALGM

BILI

MARA

SBSW

TGTX

Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial results, and market strength.

Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?

A Different Picture

Guidance

TG Therapeutics Inc (NASDAQ:TGTX) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024. 

What&#39;s Going On With TG Therapeutics Stock Tuesday?

movers image

Pre-Market Outlook

Markets

ALAR

ATSG

CSWC

EDSA

EFSH

NLSP

NSSC

NUWE

OKLO

OMIC

SIFY

STAF

VSTE

YUMC

Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

TG Therapeutics Inc

Press Releases

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

TG Therapeutics to Participate in the Evercore HealthCONx Conference

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Health Care

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Earnings

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Arcellx

ADMA Biologics

Alkermes

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

BridgeBio Pharma

Blueprint Medicines Corporation - Common Stock

Blueprint Medicines

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Grifols, S.A. - American Depositary Shares

Grifols

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals

Krystal Biotech

Legend Biotech Corporation - American Depositary Shares

Legend Biotech

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Nuvalent

Vaxcyte

PTC Therapeutics

Avidity Biosciences

Roivant Sciences

Revolution Medicines, Inc. - Common Stock

Revolution Medicines

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals

Zai Lab Limited - American Depositary Shares

Zai Lab

HC Wainwright & Co.

JP Morgan

Goldman Sachs

TD Cowen

B. Riley Securities

Comments

TG Therapeutics

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga